TY - JOUR
T1 - National South African HIV prevalence estimates robust despite substantial test non-participation
AU - Harling, G.
AU - Moyo, S.
AU - McGovern, M. E.
AU - Mabaso, M.
AU - Marra, G.
AU - Bärnighausen, T.
AU - Rehle, T.
N1 - Funding Information:
The 2012 survey was mainly funded by the President’s Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of Cooperative Agreement Number 3U2GGH000570, with additional financial support from the United Nations Children’s Fund, the South African National AIDS Council and the Bill and Melinda Gates Foundation. For this work, GH was supported by the National Institute of Child Health and Human Development (R01-HD084233). TB was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt professor award, which is funded by the German Federal Ministry of Education and Research; the Wellcome Trust; the European Commission; the Clinton Health Access Initiative; and the National Institutes of Health through the National Institute of Child Health and Human Development (R01-HD084233), the National Institute on Aging (P01-AG041710), the National Institute of Allergy and Infectious Diseases (R01-AI124389 and R01-AI112339) and the Fogarty International Center (D43-TW009775). Conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
© 2017, South African Medical Association. All rights reserved.
PY - 2017/7
Y1 - 2017/7
N2 - Background. South African (SA) national HIV seroprevalence estimates are of crucial policy relevance in the country, and for the worldwide HIV response. However, the most recent nationally representative HIV test survey in 2012 had 22% test non-participation, leaving the potential for substantial bias in current seroprevalence estimates, even after controlling for selection on observed factors. Objective. To re-estimate national HIV prevalence in SA, controlling for bias due to selection on both observed and unobserved factors in the 2012 SA National HIV Prevalence, Incidence and Behaviour Survey. Methods. We jointly estimated regression models for consent to test and HIV status in a Heckman-type bivariate probit framework. As selection variable, we used assigned interviewer identity, a variable known to predict consent but highly unlikely to be associated with interviewees’ HIV status. From these models, we estimated the HIV status of interviewed participants who did not test. Results. Of 26 710 interviewed participants who were invited to test for HIV, 21.3% of females and 24.3% of males declined. Interviewer identity was strongly correlated with consent to test for HIV; declining a test was weakly associated with HIV serostatus. Our HIV prevalence estimates were not significantly different from those using standard methods to control for bias due to selection on observed factors: 15.1% (95% confidence interval (CI) 12.1 - 18.6) v. 14.5% (95% CI 12.8 - 16.3) for 15 - 49-year-old males; 23.3% (95% CI 21.7 - 25.8) v. 23.2% (95% CI 21.3 - 25.1) for 15 - 49-year-old females. Conclusion. The most recent SA HIV prevalence estimates are robust under the strongest available test for selection bias due to missing data. Our findings support the reliability of inferences drawn from such data.
AB - Background. South African (SA) national HIV seroprevalence estimates are of crucial policy relevance in the country, and for the worldwide HIV response. However, the most recent nationally representative HIV test survey in 2012 had 22% test non-participation, leaving the potential for substantial bias in current seroprevalence estimates, even after controlling for selection on observed factors. Objective. To re-estimate national HIV prevalence in SA, controlling for bias due to selection on both observed and unobserved factors in the 2012 SA National HIV Prevalence, Incidence and Behaviour Survey. Methods. We jointly estimated regression models for consent to test and HIV status in a Heckman-type bivariate probit framework. As selection variable, we used assigned interviewer identity, a variable known to predict consent but highly unlikely to be associated with interviewees’ HIV status. From these models, we estimated the HIV status of interviewed participants who did not test. Results. Of 26 710 interviewed participants who were invited to test for HIV, 21.3% of females and 24.3% of males declined. Interviewer identity was strongly correlated with consent to test for HIV; declining a test was weakly associated with HIV serostatus. Our HIV prevalence estimates were not significantly different from those using standard methods to control for bias due to selection on observed factors: 15.1% (95% confidence interval (CI) 12.1 - 18.6) v. 14.5% (95% CI 12.8 - 16.3) for 15 - 49-year-old males; 23.3% (95% CI 21.7 - 25.8) v. 23.2% (95% CI 21.3 - 25.1) for 15 - 49-year-old females. Conclusion. The most recent SA HIV prevalence estimates are robust under the strongest available test for selection bias due to missing data. Our findings support the reliability of inferences drawn from such data.
UR - http://www.scopus.com/inward/record.url?scp=85021831969&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021831969&partnerID=8YFLogxK
U2 - 10.7196/SAMJ.2017.v107i7.11207
DO - 10.7196/SAMJ.2017.v107i7.11207
M3 - Article
C2 - 29025448
AN - SCOPUS:85021831969
VL - 107
SP - 590
EP - 594
JO - South African Medical Journal
JF - South African Medical Journal
SN - 0038-2469
IS - 7
ER -